UK: Changes To The Approved Persons Regime

Last Updated: 20 January 2009
Article by Simon Morris

FSA has decided, post Northern Rock, to increase the rigour of its day-to-day supervision, especially where the competence of firms' management is in issue, and has therefore reviewed its approach to the significant influence controlled functions. These proposals are contained in the FSA Consultation paper CP08/25: The approved persons regime - significant influence function review.

The proposals in summary

FSA proposes to:

  • Extend the definition of the existing CF1 (director) and CF2 (non-executive director) controlled functions to include individuals exercising significant influence on a regulated firm from a parent undertaking or holding company unregulated by FSA or an EU financial services regulator.
  • Clarify the role of non-executive directors;
  • Extend the definition of the CF29 controlled function to include all proprietary traders. Recent events suggest that the risks of proprietary trading in firms and the current market situation now warrant review of the position of all proprietary traders in relation to the approved persons regime. FSA considers the ability to take enforcement action may assist in deterring both senior and junior proprietary traders from undertaking activity for short term advantage that is either unauthorised, exposes the firm to risk of financial failure or jeopardises confidence in UK markets. (CP08/25 para 5.3)
  • Amend the application of the approved persons regime to UK branches of third country firms so that all the controlled functions may apply. Currently only certain controlled functions apply to UK branches of third country firms and CF1 and CF2 do not apply. FSA now wants to change this to reflect current corporate governance arrangements and to ensure regulatory consistency between third country firms who form subsidiaries in the UK and third country firms that branch into the UK.
  • Extend the rule obliging firms to provide references to all controlled functions.

To view the article in full, please see below:




Full Article

FSA has decided, post Northern Rock, to increase the rigour of its day-to-day supervision, especially where the competence of firms' management is in issue, and has therefore reviewed its approach to the significant influence controlled functions. These proposals are contained in the FSA Consultation paper CP08/25: The approved persons regime - significant influence function review.

The proposals in summary

FSA proposes to

  • Extend the definition of the existing CF1 (director) and CF2 (non-executive director) controlled functions to include individuals exercising significant influence on a regulated firm from a parent undertaking or holding company unregulated by FSA or an EU financial services regulator.
  • Clarify the role of non-executive directors;
  • Extend the definition of the CF29 controlled function to include all proprietary traders. Recent events suggest that the risks of proprietary trading in firms and the current market situation now warrant review of the position of all proprietary traders in relation to the approved persons regime. FSA considers the ability to take enforcement action may assist in deterring both senior and junior proprietary traders from undertaking activity for short term advantage that is either unauthorised, exposes the firm to risk of financial failure or jeopardises confidence in UK markets. (CP08/25 para 5.3)
  • Amend the application of the approved persons regime to UK branches of third country firms so that all the controlled functions may apply. Currently only certain controlled functions apply to UK branches of third country firms and CF1 and CF2 do not apply. FSA now wants to change this to reflect current corporate governance arrangements and to ensure regulatory consistency between third country firms who form subsidiaries in the UK and third country firms that branch into the UK.
  • Extend the rule obliging firms to provide references to all controlled functions.

FSA has already decided to:

  • Hold individuals exercising significant influence over authorised firms accountable for poor conduct at those firms with regard to regulated activities. FSA has to date focussed on cases of dishonesty or lack of integrity. In the future, FSA will now investigate more individuals and also review the competence of significant influence function holders. Comment: this is not, in practice, a distinction that FSA currently draws. FSA has taken action against senior management for failings in their firms, but only where it can demonstrate a close link between the manager and the misconduct – which is generally only possible in the smallest firms.
  • Interview more applicants for significant influence functions at the largest firms. FSA supervisors will seek assurance that they can rely on those holding significant influence functions to make more principles based regulation a reality at their firms. Comment: this practice commenced some months back, starting with appointees to troubled firms and entrants from outside the industry. The interviews may be conducted by a "grey panther" – a retired industry figure – together with Supervision. The aim of the interview is to check the applicant's understanding of FSA's regulatory requirements and to enable FSA to understand his or her plans for the firm.
  • Change Form A (Application for a controlled function) to require firms to provide supplementary information about the competence and capability of the candidate. (CP08/25 para 2.2)

FSA's proposals for non-executive directors

FSA considers that firms must have high quality non-executive directors committed to ensuring that their firms are run effectively, and views the duties of a non-executive to cover the following responsibilities:

  • Assisting executive colleagues within the firm's governing body in setting and monitoring the firm's strategy
  • Providing an independent perspective to the overall running of the business, scrutinising the approach of executive management, the firm's performance and standards of conduct
  • Carrying out other responsibilities as assigned by the board, for example as a member of a board committee, such as an audit or remuneration committee. (CP08/25 para 4.2)

FSA recognises the valuable role of the non-executive director within regulated firms, and expects them to ask challenging questions in order to understand (and if necessary, positively influence) the business model and inherent risks within the regulated firm. FSA is proposing changes to the APER Code of Practice to better reflect the duties of non-executive directors. FSA states that it will hold non-executive directors accountable, as well as the firm and its executives, if there is evidence to suggest that they have failed to fulfil their duties with competence and/or integrity. (CP08/25 para 2.4)

The draft rules for non-executive directors will require a non-executive director to discharge three functions:

  • Provide an independent perspective, and constructively challenge and help develop proposals on strategy.
  • Scrutinise the performance and approach of senior managers in meeting agreed goals, objectives, and standards of conduct.
  • Establish and continually maintain his confidence in the:
    (a) Conduct of the firm;
    (b) Performance of senior management;
    (c) Development of the firm's business strategy;
    (d) Adequacy of financial controls;
    (e) Risk management;
    (f) Appropriateness of remuneration;
    (g) Appointment and replacement of key personnel; and
    (h) Plans for management development and succession.

Comment: while these draft rules record the duties normally expected of a non-executive director, they are significant for two reasons. First, they effectively codify FSA's requirements and thus indicate the areas that an NED should cover. This in turn raises the expectation that an NED will keep records to indicate how he or she has performed the role – what they have read, what questions they have asked, and what action they have instigated. Second, it presages enforcement action – this is FSA making it clear that, when misconduct occurs, it will scrutinise the acts and omissions of the firm's NEDs and act against those that were ineffectual.

FSA's plan to extend controlled functions to holding companies

FSA considers that the current regime for individual approval captures individuals in matrix management structures if there has been a significant delegation of authority for management decisions by the governing body of an authorised firm (by CF29). However, the regime does not necessarily reflect the increasing significant influence exerted on an authorised firm by individuals based in parent undertakings or holding companies to which the authorised firm is accountable. (CP08/25 para 3.3)

Which firms?

FSA therefore proposes to apply the extended CF1 and CF2 to individuals in the following types of company exercising a significant influence over an FSA authorised firm:

  • Regulated and unregulated UK parent undertakings and holding companies;
  • Regulated and unregulated third country parent undertakings and holding companies; and
  • EEA unregulated parent undertakings and holding companies.
    But not UK branches of an EEA regulated company, nor UK incorporated authorised firms with an EEA regulated parent company. (CP08/25 paras 3.10, 11)

Which individuals?

FSA proposes to extend the definitions of both CF1 and CF2 to include individuals, such as directors, non-executive directors or senior managers, employed by a parent undertaking or holding company whose decisions, opinions or actions are regularly taken into account by the governing body of the authorised firm and therefore likely to have a significant influence on the conduct of an authorised firm's affairs.

Comment: this is akin to the Companies Act definition of a "shadow director" and contains the two elements of authority and regularity. In other words, a parent's director or senior manager may fall within the extended CF1/2 definition if (i) his or her decisions, opinions or actions are authoritative and thus considered by the FSA regulated firm before reaching a decision, and (ii) this is a frequent occurrence. (CP08/25 para 3.7)

When?

Not every parent/subsidiary relationship will result in the parent's senior managers exercising significant influence over the UK subsidiary – the issue will in each case be a matter of fact. If the governing body of an authorised firm is sufficiently robust and autonomous then FSA would not expect individuals in any company to which the firm is accountable to need approval.

But if governance arrangements in the authorised firm rely heavily on the governing bodies or other individuals within another group company then the extended controlled functions are likely to apply. FSA gives the following examples:

For the extended CF1 role

  • The chairman of a group audit committee.
  • A senior manager working for the holding company who is involved in taking decisions for or influencing the UK firm, or who has significant influence in setting the objectives for, and remuneration of, the UK directors.

For the extended CF 2 role

  • A non executive director of the group holding company who is a member of the group audit committee
  • Or who sets and monitors business strategy for, or who has oversight over management performance in, the UK subsidiary. (CP08/25 paras 3.8, 13; draft rules)

Who must identify affected individuals?

The firms themselves – FSA believes that robust corporate governance arrangements should identify where individuals in parent undertakings and holding companies are exercising a significant influence on the authorised firm. FSA will be looking closely at corporate governance arrangements to see if they sufficiently identify where significant influence lies. (CP08/25 para 3.12)

Next steps

Practical consequences

If this proposal is implemented, it will extend FSA regulation to senior managers of unregulated firms who are not otherwise subject to UK regulation and who have no direct responsibility for the management of those firms. The obligations arising from individual FSA approval as a person holding a significant influence position do not correspond to the role performed by a manager working for an unregulated firm who may influence, but holds no office in, a UK regulated subsidiary.

In particular, FSA may find it difficult to assess the fitness and properness of such an individual who does not, and otherwise has no requirement to, operate in the regulated environment. Furthermore, it is inappropriate to require an unregulated individual to fulfil the requirements of APER 5 – 7. These statements of principle for approved persons in essence require an individual registered as CF 1 or 2 to ensure that the firm is being run compliantly. It is impracticable for FSA to impose this requirement on an individual who has no executive role in a regulated firm.

Challenge

Firms should challenge FSA over the justification for these steps. The cost benefit analysis is weak, and there is no identification of any regulatory failure. Furthermore, the imposition of APER 5 – 7 appears to be disproportionate and impracticable.

If FSA does proceed with this proposal, then unregulated holding companies would be well advised to reconsider their method of operating, possibly changing the roles of individuals working in holding companies so that they plainly fall outwith FSA's definitions. This would be a regrettable step to have to take, because it would deprive the regulated firm of the benefit of group oversight that has so far proved beneficial and in respect of which FSA has no sound objections.

This article was written for Law-Now, CMS Cameron McKenna's free online information service. To register for Law-Now, please go to www.law-now.com/law-now/mondaq

Law-Now information is for general purposes and guidance only. The information and opinions expressed in all Law-Now articles are not necessarily comprehensive and do not purport to give professional or legal advice. All Law-Now information relates to circumstances prevailing at the date of its original publication and may not have been updated to reflect subsequent developments.

The original publication date for this article was 19/01/2009.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.